Research Library
IGF-LR3 research
6 articles to explore, with links to 6 original sources.
About IGF-LR3
IGF-LR3 generally denotes Long R3 IGF-1, an engineered 83-amino-acid analogue. Supplier descriptions emphasize reduced binding-protein interaction, cell-culture growth support, and a structure distinct from native human IGF-1.
Understand the science
How laboratories distinguished intact LR3 from breakdown products
IGF-LR3 is an engineered 83-amino-acid version of insulin-like growth factor 1. It includes a 13-residue extension at the beginning and an arginine substitution in the original sequence. How did researchers distinguish the intact molecule from closely related compounds in blood samples?
2 sources (1992, 2021)
Explore study findings
What happened to kidney filtration in an older rat experiment
IGF-LR3, or Long R3 IGF-1, is an engineered insulin-like growth factor with a 13-residue extension and an arginine substitution. An animal study examined whether changes in growth-related measurements after kidney injury were accompanied by better kidney filtration.
2 sources (1992, 1994)
Check methods and identity
What yeast production and a cell proliferation assay can establish
IGF-LR3 is an 83-residue relative of human insulin-like growth factor 1 with an extension and an arginine substitution. One research question is how investigators test whether a recombinant preparation retains biological activity.
2 sources (1992, 2023)
Interpret the evidence
What a 2026 cell-culture study can tell us about one ingredient in a complex medium
IGF-LR3, or Long R3 IGF-1, is an engineered 83-residue analogue of human insulin-like growth factor 1. It has an extension at the beginning and an arginine substitution at position three of the original IGF-1 sequence.
2 sources (1992, 2026)
Why an amyloid plaque change did not establish cognitive improvement
IGF-LR3 is an engineered form of insulin-like growth factor 1 with a 13-residue extension and an arginine substitution. In a mouse study, researchers asked whether exposing the brain to this variant changed amyloid deposits and performance on behavioral tests.
2 sources (1992, 2024)
Why Long R3 did not appear equally potent in every cell system
IGF-LR3 is an engineered version of human insulin-like growth factor 1. It adds 13 residues to the beginning and replaces glutamate with arginine at the third position of the original sequence. Researchers used this design to ask how binding proteins change a growth factor's apparent potency.
1 source (1992)
